§ 13F · FUND PROFILE
Caligan Partners LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 24Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$1214.8T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | LQDA | LIQUIDIA CORPORATION | 8.12M | $280.0T | 23.1% | NEW |
| 2 | ABVX | ABIVAX SA | 1.45M | $195.8T | 16.1% | NEW |
| 3 | RVMD | REVOLUTION MEDICINES INC | 1.28M | $102.3T | 8.4% | NEW |
| 4 | MLYS | MINERALYS THERAPEUTICS INC | 2.77M | $100.6T | 8.3% | NEW |
| 5 | MLYS | MINERALYS THERAPEUTICS INC | 2.30M | $83.4T | 6.9% | NEW |
| 6 | PCVX | VAXCYTE INC | 1.70M | $78.7T | 6.5% | NEW |
| 7 | EXEL | EXELIXIS INC | 1.55M | $68.1T | 5.6% | NEW |
| 8 | ADMA | ADMA BIOLOGICS INC | 3.01M | $54.9T | 4.5% | NEW |
| 9 | TNGX | TANGO THERAPEUTICS INC | 3.73M | $33.0T | 2.7% | NEW |
| 10 | INBX | INHIBRX BIOSCIENCES INC | 324K | $25.6T | 2.1% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE CALIGAN SIGNAL
AC read
Caligan Partners LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed